Search Within

Marc Rosenblum

Formats
  1. Journal Article (292)
  2. Meeting Abstract (112)
  3. Book Section (11)
  4. Research Letter (3)
  5. Review (3)
  6. Conference Paper (2)
  7. Book Whole (1)
Groups
  1. Department of Pathology and Laboratory Medicine (424)
  2. Tow Center for Developmental Oncology (TCDO) (118)
  3. GSK Faculty (105)
  4. Radiology, Department of (72)
  5. Pediatrics, Department of (63)
  6. Neuroradiology Service (60)

More Groups

People
  1. Tejus Bale (47)
  2. Lisa De Angelis (41)
  3. Marc Ladanyi (29)
  4. Elena Pentsova (27)
  5. Ingo Mellinghoff (27)
  6. Ira Dunkel (27)

More People

Years
  1. 2025 (2)
  2. 2024 (13)
  3. 2023 (19)
  4. 2022 (14)
  5. 2021 (15)
  6. 2020 (16)

More Years

Publications
  1. Neuro-Oncology (52)
  2. American Journal of Surgical Pathology (29)
  3. Journal of Neuro-Oncology (25)
  4. Journal of Neuropathology and Experimental Neurology (25)
  5. Neurology (20)
  6. Acta Neuropathologica (18)

More Publications

Publishers
  1. Oxford University Press (89)
  2. Lippincott Williams & Wilkins (56)
  3. Springer (48)
  4. Nature Publishing Group (28)
  5. Wiley Blackwell (24)
  6. Elsevier Inc. (18)

More Publishers

Results (424)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical characteristics and treatment outcomes in patients with histiocytic neoplasms harboring class 3 MAP2K1 mutations, including novel treatment with the ERK inhibitor ulixertinib
    Meeting Abstract

    Diamond, E. L.; Rosenblum, M.; Yabe, M.; Petrova-Drus, K.; Francis, J. H.; Rampal, R. K.; Lacouture, M. E.; Rotemberg, V. M.; Hatzoglou, V.; Young, R.; more...
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • A multinational series of 26 patients with mixed histiocytic neoplasms highlighting a diverse mutational landscape and superior efficacy of targeted therapies
    Meeting Abstract

    Diamond, E. L.; Durham, B. H.; Reiner, A. S.; Yabe, M.; Petrova-Drus, K.; Francis, J. H.; Rampal, R. K.; Ulaner, G. A.; Reddy, R.; Lacouture, M. E.; more...
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • De novo adamantinomatous craniopharyngioma with long-term pre-diagnostic imaging
    Journal Article

    Bou-Nassif, R.; El Ahmadieh, T. Y.; Abou-Mrad, Z.; Rosenblum, M.; Cohen, M. A.; Tabar, V.
    Neurochirurgie (2023)

    Fulltext@MSK | Save
  • Multi-institutional study of the frequency, genomic landscape, and outcome of IDH-mutant glioma in pediatrics
    Journal Article

    Yeo, K. K.; Alexandrescu, S.; Cotter, J. A.; Vogelzang, J.; Bhave, V.; Li, M. M.; Ji, J.; Benhamida, J. K.; Rosenblum, M. K.; Bale, T. A.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Non-invasive diagnosis of IDH-mutant brainstem gliomas
    Meeting Abstract

    Kushnirsky, M.; Thakur, S.; Karajannis, M.; Bale, T.; Rosenblum, M.; Malani, R.; Gavrilovic, I. T.; Schaff, L.; Pentsova, E.; Grommes, C.; more...
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Correlative performance of cerebrospinal fluid (CSF) circulating tumor cells (CTC) and cell-free tumor-derived DNA (ctDNA) in leptomeningeal metastases (LM) and parenchymal brain metastases (BM)
    Meeting Abstract

    Diaz, M.; Reiner, A.; Huereca, C.; Young, R.; Arcila, M.; Rosenblum, M.; Ramanathan, L.; Bale, T.; Pentsova, E.
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Radiation induced high grade gliomas: A single center experience
    Meeting Abstract

    Joshirao, M.; Sait, S. F.; Bouvier, N.; Hill, K.; Khakoo, Y.; Kramer, K.; Gilheeney, S.; Wolden, S.; Nolan, C.; Schaff, L.; more...
    Pediatric Blood and Cancer (2022)

    Fulltext@MSK | Save
  • Upfront molecular targeted therapy for the treatment of BRAF-mutant pediatric high-grade glioma
    Meeting Abstract

    Rosenberg, T.; Yeo, K. K.; Mauguen, A.; Alexandrescu, S.; Prabhu, S. P.; Tsai, J. W.; Malinowski, S.; Joshirao, M.; Parikh, K.; Sait, S. F.; more...
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Clinical characteristics and treatment outcomes in patients with histiocytic neoplasms harboring class 3 MAP2K1 mutations, including treatment with the ERK inhibitor ulixertinib
    Meeting Abstract

    Diamond, E. L.; Yabe, M.; Petrova-Drus, K.; Rosenblum, M.; Rotemberg, V.; Lacouture, M. E.; Rampal, R.; Francis, J.; Knoerzer, D.; Kreider, B.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Inducible transgenic cerebral organoids model oncogene dependence in pediatric tumorigenesis
    Meeting Abstract

    Graham, M. S.; Codega, P.; Campos, C.; Rosenblum, M. K.; Antonescu, C. R.; Nandakumar, S.; Benhamida, J. K.; Bale, T. A.; von Deimling, A.; Socci, N. D.; more...
    Annals of Neurology (2022)

    Fulltext@MSK | Save